Nasenspray Kinder (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride acts as a selective alpha‑adrenergic agonist. By stimulating alpha receptors on nasal blood vessels, it causes vasoconstriction, which reduces swelling of the nasal mucosa and opens the airway, providing rapid decongestion.

The exact dosing regimen for Nasenspray Kinder is determined by a qualified healthcare professional based on the child’s age, weight, and clinical condition. Prescribers typically follow local labeling guidance, and patients should follow the instructions provided by their clinician.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk, and only after consultation with a healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Nasenspray Kinder contains Xylometazoline, an imidazoline‑type decongestant. Compared with oxymetazoline, it has a similar onset of action but may be formulated at lower concentrations for pediatric use, offering effective relief while aiming to minimize systemic exposure.

Store Nasenspray Kinder at room temperature, preferably below 25 °C. Keep the bottle in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use.

The spray is applied directly into each nostril while the child is in an upright position. The prescriber will indicate the number of sprays per nostril and the maximum duration of treatment, usually not exceeding three to five consecutive days.

Serious but rare risks include hypertension, cardiac arrhythmias, and rebound nasal congestion after prolonged use. If any signs of high blood pressure, irregular heartbeat, or worsening blockage occur, discontinue use and seek medical attention promptly.

Children under two years of age should not use the product without medical supervision. Patients with known hypersensitivity to Xylometazoline or other imidazoline derivatives, as well as those with severe cardiovascular disease, should avoid it unless directed by a physician.